High-Dose-Rate Brachytherapy in the Curative Treatment of Patients With Localized Prostate Cancer (original) (raw)
Focal therapy of prostate cancer: energies and procedures
Gregory Bozzini
Urologic Oncology: Seminars and Original Investigations, 2013
View PDFchevron_right
High-Dose-Rate Monotherapy for Localized Prostate Cancer: 10-Year Results
Thạnh Lại Văn
International Journal of Radiation Oncology*Biology*Physics, 2016
View PDFchevron_right
Postprostatectomy radiotherapy for high-risk prostate cancer
Franz Quehenberger
2002
View PDFchevron_right
Radiobiological comparison of two radiotherapy treatment techniques for high-risk prostate cancer
José López Torrecilla
Reports of Practical Oncology & Radiotherapy, 2013
View PDFchevron_right
719 poster LONG-TERM RESULTS OF HIGH-DOSE EBRT AND EBRT WITH BRACHYTHERAPY BOOST IN TREATMENT OF PROSTATE CANCER PATIENTS
Marzena Gawkowska-suwinska
Radiotherapy and Oncology, 2011
View PDFchevron_right
Prostate brachytherapy in New South Wales: patterns of care study and impact of caseload on treatment quality
Raj Jagavkar
Journal of Contemporary Brachytherapy, 2014
View PDFchevron_right
Dose escalation with external beam radiation therapy and high-dose-rate brachytherapy combined with long-term androgen deprivation therapy in high and very high risk prostate cancer: Comparison of two consecutive high-dose-rate schemes
Marta Moreno-jiménez
Brachytherapy, 2016
View PDFchevron_right
Permanent prostate brachytherapy: Pathologic implications as assessed on radical prostatectomy specimens of broadening selection criteria for monotherapy
Lance A Mynderse
2006
View PDFchevron_right
Late toxicity after single dose HDR prostate brachytherapy and EBRT for localized prostate cancer: Clinical and dosimetric predictors in a prospective cohort study
Francisco Casquero
Radiotherapy and Oncology, 2019
View PDFchevron_right
Brachytherapy Improves 10-year Overall Survival Compared to Prostatectomy Alone in Young Men (≤60) with Low- and Intermediate-Risk Prostate Cancer: An NCDB Analysis
Hani Ashamalla
International Journal of Radiation Oncology Biology Physics, 2018
View PDFchevron_right
Low Dose Rate Brachytherapy (LDR-BT) as monotherapy for early stage prostate cancer in Italy: Practice and outcome analysis in a series of 2237 patients from 11 Institutions
N. Di Muzio
The British Journal of Radiology, 2016
View PDFchevron_right
The Case for Brachytherapy: Why It Deserves a Renaissance
Nikhil Thaker
Advances in Radiation Oncology, 2021
View PDFchevron_right
Role of postradical prostatectomy irradiation in carcinoma of the prostate
Carlos Perez
Seminars in Radiation Oncology, 1993
View PDFchevron_right
15: Acura Analysis of PSA Kinetics and Late Treatment Related Toxicity in a Phase 2 Randomized Pilot Study Comparing High Dose Rate Brachytherapy and Low Dose Rate Brachytherapy as Monotherapy in Localized Prostate Cancer
Andre-Guy Martin
Radiotherapy and Oncology, 2020
View PDFchevron_right
A randomized trial of external beam radiotherapy versus cryoablation in patients with localized prostate cancer
Kiril Trpkov
Cancer, 2010
View PDFchevron_right
Radiation therapy and androgen deprivation in the management of high risk prostate cancer
Luis Souhami
International braz j urol, 2011
View PDFchevron_right
S206 Radiation therapy for high risk subgroup of prostate cancer patients
C. Fliatouras
European Urology Supplements, 2013
View PDFchevron_right
Palliative radiation therapy for localized prostate symptoms in hormone refractory prostate cancer
V DO
Australasian Radiology, 2007
View PDFchevron_right
Brachytherapy for Prostate Cancer: A Systematic Review
Vassilis Kouloulias
Advances in Urology, 2009
View PDFchevron_right
Results of combined radiotherapy and hormonal treatment of prostate cancer patients with initial PSA value >40ng/ml
Buril Jan
Reports of Practical Oncology & Radiotherapy, 2012
View PDFchevron_right
Postradiation therapy adenosquamous cell carcinoma of the prostate
Mohamed Helal
Prostate Cancer and Prostatic Diseases, 2000
View PDFchevron_right
International phase II trial of dose escalation to dominant intraprostatic lesion (DIL) with real-time high dose rate (HDR) brachytherapy
Francisco Casquero
Reports of Practical Oncology & Radiotherapy, 2013
View PDFchevron_right
High dose brachytherapy (real time) in patients with intermediate-or high-risk prostate cancer: technical description and preliminary experience
Angel Calderon
Clinical and …, 2005
View PDFchevron_right
Brachytherapy in the Management of Prostate Cancer
Richard Choo
Surgical oncology clinics of North America, 2017
View PDFchevron_right
Acute/Late Toxicities and Predictors of Erectile Function in Patients with Intermediate Risk Prostate Cancer Treated with Combined Modality External Beam Radiotherapy and Interstitial Brachytherapy
Weisi Yan
International Journal of Radiation Oncology Biology Physics, 2008
View PDFchevron_right